VEDOLIZUMAB

vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices

VEDOLIZUMAB (12644L)

vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices
12644L
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment with subcutaneous form
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 2 # of repeats: 0 DPMQ: $1,663.98 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Entyvio